These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 31327288)

  • 1. New classifications of gastroesophageal reflux disease: an improvement for patient management?
    Ribolsi M; Giordano A; Guarino MPL; Tullio A; Cicala M
    Expert Rev Gastroenterol Hepatol; 2019 Aug; 13(8):761-769. PubMed ID: 31327288
    [No Abstract]   [Full Text] [Related]  

  • 2. Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they?
    de Bortoli N; Martinucci I; Savarino E; Bellini M; Bredenoord AJ; Franchi R; Bertani L; Furnari M; Savarino V; Blandizzi C; Marchi S
    Neurogastroenterol Motil; 2014 Jan; 26(1):28-35. PubMed ID: 23992024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined esophageal multichannel intraluminal impedance and pH monitoring (MII -pH) in the diagnostics and treatment of gastroesophageal reflux disease and its complications.
    Masiak W; Wallner G; Wallner J; Pedowski T; Solecki M
    Pol Przegl Chir; 2011 Sep; 83(9):488-96. PubMed ID: 22166737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy.
    Galindo G; Vassalle J; Marcus SN; Triadafilopoulos G
    Dis Esophagus; 2013 Jul; 26(5):443-50. PubMed ID: 22862422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Prevalence of Rome IV Nonerosive Esophageal Phenotypes in Children.
    Mahoney LB; Nurko S; Rosen R
    J Pediatr; 2017 Oct; 189():86-91. PubMed ID: 28711175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastroesophageal reflux disease-related symptom recurrence in patients discontinuing proton pump inhibitors for Bravo
    Schey R; Alla SP; Midani D; Parkman HP
    Rev Gastroenterol Mex; 2017; 82(4):277-286. PubMed ID: 28385467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ESNM/ANMS consensus paper: Diagnosis and management of refractory gastro-esophageal reflux disease.
    Zerbib F; Bredenoord AJ; Fass R; Kahrilas PJ; Roman S; Savarino E; Sifrim D; Vaezi M; Yadlapati R; Gyawali CP
    Neurogastroenterol Motil; 2021 Apr; 33(4):e14075. PubMed ID: 33368919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Between GERD and NERD: the relevance of weakly acidic reflux.
    de Bortoli N; Ottonello A; Zerbib F; Sifrim D; Gyawali CP; Savarino E
    Ann N Y Acad Sci; 2016 Sep; 1380(1):218-229. PubMed ID: 27472432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indications of 24-h esophageal pH monitoring, capsule pH monitoring, combined pH monitoring with multichannel impedance, esophageal manometry, radiology and scintigraphy in gastroesophageal reflux disease?
    Vardar R; Keskin M
    Turk J Gastroenterol; 2017 Dec; 28(Suppl 1):S16-S21. PubMed ID: 29199161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastroesophageal reflux disease: presentation and assessment of a common, challenging disorder.
    Soll AH; Fass R
    Clin Cornerstone; 2003; 5(4):2-14; discussion 14-7. PubMed ID: 15101491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The diagnosis of gastroesophageal reflux disease.
    Dughera L; Navino M; Cassolino P; Pellicano R
    Minerva Gastroenterol Dietol; 2007 Jun; 53(2):143-52. PubMed ID: 17557042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Esophageal intraluminal baseline impedance differentiates gastroesophageal reflux disease from functional heartburn.
    Kandulski A; Weigt J; Caro C; Jechorek D; Wex T; Malfertheiner P
    Clin Gastroenterol Hepatol; 2015 Jun; 13(6):1075-81. PubMed ID: 25496815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The proton pump inhibitor test and the diagnosis of gastroesophageal reflux disease.
    Pace F; Pace M
    Expert Rev Gastroenterol Hepatol; 2010 Aug; 4(4):423-7. PubMed ID: 20678016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of Salivary Pepsin in the Diagnosis of Gastroesophageal Reflux Disease (GERD) Evaluated Using High-Resolution Manometry and 24-Hour Multichannel Intraluminal Impedance-pH Monitoring.
    Guo Z; Wu Y; Chen J; Zhang S; Zhang C
    Med Sci Monit; 2020 Nov; 26():e927381. PubMed ID: 33220027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Underlying Mechanisms and Management of Refractory Gastroesophageal Reflux Disease].
    Lee KJ
    Korean J Gastroenterol; 2015 Aug; 66(2):70-4. PubMed ID: 26289239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Twice-daily proton pump inhibitor therapy does not decrease the frequency of reflux episodes during nocturnal recumbency in patients with refractory GERD: analysis of 200 patients using multichannel intraluminal impedance-pH testing.
    Clayton SB; Rife CC; Singh ER; Kalbfleisch JH; Castell DO
    Dis Esophagus; 2012; 25(8):682-6. PubMed ID: 22292567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Gastroesophageal Reflux by Combined Multichannel Intraluminal Impedance and pH Monitoring and Esophageal Motility Patterns in Children with Esophageal Atresia.
    Tong S; Mallitt KA; Krishnan U
    Eur J Pediatr Surg; 2016 Aug; 26(4):322-31. PubMed ID: 26445355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GERD phenotypes from pH-impedance monitoring predict symptomatic outcomes on prospective evaluation.
    Patel A; Sayuk GS; Kushnir VM; Chan WW; Gyawali CP
    Neurogastroenterol Motil; 2016 Apr; 28(4):513-21. PubMed ID: 26686239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in diagnostic testing for gastroesophageal reflux disease.
    Naik RD; Vaezi MF
    Expert Rev Gastroenterol Hepatol; 2017 Jun; 11(6):531-537. PubMed ID: 28317452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Esophageal reflux hypersensitivity: Non-GERD or still GERD?
    Savarino V; Marabotto E; Zentilin P; Demarzo MG; Pellegatta G; Frazzoni M; De Bortoli N; Tolone S; Giannini EG; Savarino E
    Dig Liver Dis; 2020 Dec; 52(12):1413-1420. PubMed ID: 33097427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.